Citation: A. Vermes et al., INDIVIDUALIZATION OF CANCER-THERAPY BASED ON CYTOCHROME-P450 POLYMORPHISM - A PHARMACOGENETIC APPROACH, Cancer treatment reviews, 23(5-6), 1997, pp. 321-339
Authors:
FREYER G
LIGNEAU B
TRANCHAND B
ARDIET C
SERREDEBEAUVAIS F
TRILLETLENOIR V
Citation: G. Freyer et al., PHARMACOKINETIC STUDIES IN CANCER-CHEMOTHERAPY - USEFULNESS IN CLINICAL-PRACTICE, Cancer treatment reviews, 23(3), 1997, pp. 153-169
Authors:
ABKEN H
HOMBACH A
HEUSER C
SIRCAR R
POHL C
REINHOLD U
Citation: H. Abken et al., CHIMERIC T-CELL RECEPTORS - HIGHLY SPECIFIC TOOLS TO TARGET CYTOTOXICT-LYMPHOCYTES TO TUMOR-CELLS, Cancer treatment reviews, 23(2), 1997, pp. 97-112
Citation: Wr. Bezwoda, THE TREATMENT OF DISSEMINATED MALIGNANT-MELANOMA WITH SPECIAL REFERENCE TO THE ROLE OF INTERFERONS, VINCA ALKALOIDS AND TAMOXIFEN, Cancer treatment reviews, 23(1), 1997, pp. 17-34
Authors:
NEWLANDS ES
STEVENS MFG
WEDGE SR
WHEELHOUSE RT
BROCK C
Citation: Es. Newlands et al., TEMOZOLOMIDE - A REVIEW OF ITS DISCOVERY, CHEMICAL-PROPERTIES, PRECLINICAL DEVELOPMENT AND CLINICAL-TRIALS, Cancer treatment reviews, 23(1), 1997, pp. 35-61
Authors:
COLEMAN R
CARR S
HOWELL A
MARTIN C
SAINSBURY R
MANIFOLD I
Citation: R. Coleman et al., THE ROLE OF GENETIC TESTING IN BREAST-CANCER BY THE YEAR 2000 - QUESTIONS AND ANSWERS, Cancer treatment reviews, 23, 1997, pp. 19-22